Cellomics Launches the KineticScan® HCS Reader Version 2.2.0
Pittsburgh, PA (June 7, 2005). – Cellomics, Inc., the creator of and market leader in High Content Screening (HCS), announced today the launch of an upgrade for their KineticScan HCS Reader instrument platform. Known for its robust imaging and complete informatics solution, the KineticScan HCS Reader (KSR) enables complete live-cell, kinetic, quantitative imaging of cell-based assays for HCS. With this upgrade, scientists will now have the ability to use Cellomics’ extensive portfolio of BioApplication image analysis modules for both fixed end-point and live-cell kinetic analysis in an “on-the-fly” mode on the KSR. In addition, the KSR includes a patented motility module which tracks live cells over an extended time course, plus reports features such as persistence, acceleration, and directionality on a well-by-well, or cell-by-cell basis.
Finally, Cellomics adds the ability for scientists to modify the fully-functional, integrated pipettor from a multi-channel to a single-channel configuration enabling optimal flexibility in fluid handling that matches demanding assay needs. These enhancements deliver increased productivity, reliability, and ease-of-use to the world’s largest user base of HCS instrumentation.
“Scientists now have the ability to calculate essential motility and kinetic calculations and then couple that with the power of the proven BioApplication modules we provide” stated Scott Keefer, Product Manager for the KineticScan. “These additions along with other recommendations that were implemented from our extensive and productive user base makes the KSR the most complete and powerful commercial imaging platform available.” “The performance increases afforded by this upgrade enables validation of more live-cell assays than ever before, including monitoring calcium transients, ion channels, membrane potential, and much, much more” added Jeffrey R. Haskins, Ph.D., VP of Technology & Product Development. Daniel J. Calvo, President and CEO of Cellomics, added “this upgrade provides users of the KineticScan access to the entire portfolio of Cellomics tools, driving the live-cell HCS market further into the discovery of complex biological processes.” Calvo continued, “The KSR provides customers with the ultimate in High Content Analysis allowing biologists to explore a myriad of biological mechanisms in real time automated fashion.”
About Cellomics
Cellomics, Inc. is automating drug discovery through a unique, cell-based assay platform that addresses the needs of Drug Discovery and Systems Biology groups by offering complete systems for High Content Screening (HCS). The platform includes HCS instrumentation (both fixed end-point and kinetic systems), informatics, cellular image analysis software (BioApplications), fluorescent reagents, kits, cell lines, and multiparametric assays. When applied to early drug discovery, this platform is proving to reduce the 'idea-to-discovery' cycle time in drug discovery, while increasing the probability of the therapeutic success of leads as well as enhancing throughput in systems biology and basic research. Cellomics’ proprietary platforms, including the ArrayScan® and KineticScan HCS Readers, along with BioApplications software and High Content Informatics (HCi™) suite, are in use at multiple sites within all of the top fifteen pharmaceutical companies, as well as leading pharmaceutical and biotechnology companies and academic centers globally. For more information about Cellomics, visit our website at www.cellomics.com. For further information, contact: Judy P. Masucci, Ph.D. Director of Marketing Cellomics, Inc. 100 Technology Drive Pittsburgh, PA 15219 412-770-2200 x 2353 412-770-2450 (fax)
http://www.cellomics.com
Last Updated ( Tuesday, 21 June 2005 )
Upcoming Events
December 13, 2008 ASCB 2008 Please visit our booth at the 49th Annual Meeting of the American Society for Cell Biology ...
Home 
Cellomics Launches the KineticScan® HCS Reader Version 2.2.0
top